Peapod Lane Capital’s Nuvation Bio NUVB Stock Holding History

Peapod Lane Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-391,745	Closed	-$1.04M	–	67
2024 Q4	$1.04M	Buy	+391,745	New	+$1.01M	1.03%	38

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Peapod Lane Capital's NUVB Position: Q1 2025 in Review

Peapod Lane Capital sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 391,745 shares — an estimated $1.04M sold.

Peapod Lane Capital first reported a position in NUVB in Q4 2024 and held it in 1 quarter. The position peaked at $1.04M in Q4 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

Peapod Lane Capital reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
Peapod Lane Capital sold 391,745 Nuvation Bio shares in Q1 2025, an estimated $1.04M.
Peapod Lane Capital first reported a position in Nuvation Bio in Q4 2024 and held it in 1 quarter.
Peapod Lane Capital's Nuvation Bio position peaked at $1.04M in Q4 2024.
161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Peapod Lane Capital's 13F filing for Q1 2025, filed 30 Apr 2025.